<DOC>
	<DOCNO>NCT03085667</DOCNO>
	<brief_summary>Closure LAA several device alternative therapy oral anticoagulation patient Atrail fibrillation . Nothing know acute influence device closure LAA secretion ANB nad BNP hormone . Therefore aim study measure ANB BNP levvels Implantation LAA closure device .</brief_summary>
	<brief_title>Impact Implantation LAA Occluder ANP BNP Level Quality Life</brief_title>
	<detailed_description>ANB BNP level measure , directly late 24 h central periphereal venous blood patient undergoing interventional LAA closure .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>patient undergo LAA closure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Left atrial appendage occluder</keyword>
	<keyword>Watchman device</keyword>
	<keyword>Atrial fibrillation</keyword>
	<keyword>atrial natriureitc peptide</keyword>
	<keyword>brain natriuretic peptide</keyword>
</DOC>